Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 506-511

  Jeppesen, Jørgen ^a,b   Hansen, Tine Willum ^c   Torp Pedersen, Christian ^b,d   Madsbad, Sten ^b,e   Ibsen, Hans ^b,c   Jørgensen, Torben ^a,b   Fenger, Mogens ^b,e  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Insulin; Insulin resistance; Ischemic heart disease; Lipids; Lipoprotein lipase

Indexed keywords

CHOLESTEROL; DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CORONARY RISK; DEATH; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GENETIC VARIATION; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; LIPIDS; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK; TRIGLYCERIDES;

EID: 77955274601     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.030     Document Type: Article

References (23)

1. Tobey T.A., Greenfield M., Kraemer F., Reaven G.M. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism 1981, 30:165-171.
2. Jeppesen J., Hollenbeck C.B., Zhou M.Y., et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995, 15:320-324.
3. Jeppesen J., Hein H.O., Suadicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998, 97:1029-1036.
4. Nordestgaard B.G., Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298:299-308.
5. Brunzell J.D., Deeb S.S. Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. The metabolic, molecular bases of inherited disease 2001, 2789-2816. McGraw-Hill, New York. 8th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
6. Merkel M., Eckel R.H., Goldberg I.J. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 2002, 43:1997-2006.
7. Rip J., Nierman M.C., Ross C.J., et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 2006, 26:1236-1245.
8. Maheux P., Azhar S., Kern P.A., Chen Y.D., Reaven G.M. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 1997, 40:850-858.
9. Hokanson J.E. Functional variants in the lipoprotein lipase gene and risk of cardiovascular disease. Curr Opin Lipidol 1999, 10:393-399.
10. Wittrup H.H., Andersen R.V., Tybjaerg-Hansen A., Jensen G.B., Nordestgaard B.G. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study. J Clin Endocrinol Metab 2006, 91:1438-1445.
11. Gagné S.E., Larson M.G., Pimstone S.N., et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Gene 1999, 55:450-454.
12. Hata A., Robertson M., Emi M., Lalouel J.M. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res 1990, 18:5407-5411.
13. Sagoo G.S., Tatt I., Salanti G., et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol 2008, 168:1233-1246.
14. Hu Y., Liu W., Huang R., Zhang X. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 2006, 47:1908-1914.
15. Jeppesen J., Hansen T.W., Rasmussen S., et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007, 49:2112-2119.
16. Jeppesen J., Hansen T.W., Olsen M.H., et al. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil 2008, 15:594-598.
17. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999, 353:1547-1557.
18. Frederiksen L., Brodbaek K., Fenger M., et al. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 2002, 8:3989-3992.
19. Drivsholm T., Ibsen H., Schroll M., Davidsen M., Borch-Johnsen K. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 2001, 18:126-132.
20. Bentzen J., Jorgensen T., Fenger M. The effect of six polymorphisms in the apoliprotein B gene on parameters of lipid metabolism in a Danish population. Clin Genet 2002, 61:126-134.
21. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
22. Wigginton J.E., Cutler D.J., Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:887-893.
23. Jensen M.K., Rimm E.B., Rader D., et al. S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective studies. Am Heart J 2009, 157:384-390.